サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386389

サブユニットワクチン市場レポート：2030年までの動向、予測、競合分析

Subunit Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

サブユニットワクチン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

サブユニットワクチンの動向と予測

世界のサブユニットワクチン市場は、2024年から2030年までのCAGRが10.5%で、2030年までに推定24億米ドルに達すると予想されます。この市場の主な促進要因は、予防接種と安全性の高いワクチンに対する需要の高まりと感染症の流行拡大です。世界のサブユニットワクチン市場の将来は、感染症、ジフテリア、破傷風、百日咳（DTP）、HPV、麻疹、おたふく風邪・風疹（MMR）市場における機会により有望視されています。

サブユニットワクチン市場の洞察

Lucintelの予測では、タンパク質抗原サブユニットワクチンは広く入手可能であり、採用されやすいことから、タンパク質が引き続き大きなセグメントとなります。

北米は感染症の蔓延率が高いため、今後も最大の地域です。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のサブユニットワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のサブユニットワクチン市場動向（2018～2023年）と予測（2024～2030年）
  • 製品タイプ別の世界のサブユニットワクチン市場
    • タンパク質抗原
    • 多糖類抗原
  • 疾患別の世界のサブユニットワクチン市場
    • 感染症
    • ジフテリア
    • 破傷風と百日咳（DTP）
    • HPV
    • 麻疹
    • おたふく風邪と風疹（MMR）
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のサブユニットワクチン市場
  • 北米のサブユニットワクチン市場
  • 欧州のサブユニットワクチン市場
  • アジア太平洋サブユニットワクチン市場
  • その他地域サブユニットワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 製品タイプ別の世界のサブユニットワクチン市場の成長機会
    • 疾患別の世界のサブユニットワクチン市場の成長機会
    • 地域別の世界のサブユニットワクチン市場の成長機会
  • 世界のサブユニットワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のサブユニットワクチン市場の生産能力拡大
    • 世界のサブユニットワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • GE Healthcare Life Sciences
  • GlaxoSmithKline
  • Merck
  • Reber Genetics
  • Sanofi
  • Algenex
  • Astellas Pharma
目次

Subunit Vaccine Trends and Forecast

The future of the global subunit vaccine market looks promising with opportunities in the infectious disease, diphtheria, tetanus and pertussis (DTP), HPV, measles, and mumps & rubella (MMR) markets. The global subunit vaccine market is expected to reach an estimated $2.4 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising demand for immunization and better safety vaccines and growing prevalence of infectious diseases.

A more than 150-page report is developed to help in your business decisions.

Subunit Vaccine by Segment

The study includes a forecast for the global subunit vaccine by product type, disease, and region.

Subunit Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Protein Antigen
  • Polysaccharide Antigen

Subunit Vaccine Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

  • Infectious Disease
  • Diphtheria
  • Tetanus and Pertussis (DTP)
  • HPV
  • Measles
  • Mumps and Rubella (MMR)
  • Others

Subunit Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Subunit Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies subunit vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the subunit vaccine companies profiled in this report include-

  • GE Healthcare Life Sciences
  • GlaxoSmithKline
  • Merck
  • Reber Genetics
  • Sanofi
  • Algenex
  • Astellas Pharma

Subunit Vaccine Market Insights

Lucintel forecasts that protein will remain the larger segment due to its widespread availability and adoptability of protein antigen subunit vaccines.

North America will remain the largest region due to the high prevalence of infectious diseases in this region.

Features of the Global Subunit Vaccine Market

Market Size Estimates: Subunit vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Subunit vaccine market size by product type, disease, and region in terms of value ($B).

Regional Analysis: Subunit vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, diseases, and regions for the subunit vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the subunit vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the subunit vaccine market size?

Answer: The global subunit vaccine market is expected to reach an estimated $2.4 billion by 2030.

Q.2 What is the growth forecast for subunit vaccine market?

Answer: The global subunit vaccine market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the subunit vaccine market?

Answer: The major drivers for this market are rising demand for immunization and better safety vaccines and growing prevalence of infectious diseases.

Q4. What are the major segments for subunit vaccine market?

Answer: The future of the subunit vaccine market looks promising with opportunities in the infectious disease, diphtheria, tetanus and pertussis (DTP), HPV, measles, and mumps & rubella (MMR) markets.

Q5. Who are the key subunit vaccine market companies?

Answer: Some of the key subunit vaccine companies are as follows:

  • GE Healthcare Life Sciences
  • GlaxoSmithKline
  • Merck
  • Reber Genetics
  • Sanofi
  • Algenex
  • Astellas Pharma

Q6. Which subunit vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that protein will remain the larger segment due to its widespread availability and adoptability of protein antigen subunit vaccines.

Q7. In subunit vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to the high prevalence of infectious diseases in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the subunit vaccine market by product type (protein antigen and polysaccharide antigen), disease (infectious disease, diphtheria, tetanus and pertussis (DTP), HPV, measles, mumps and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Subunit Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Subunit Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Subunit Vaccine Market by Product Type
    • 3.3.1: Protein Antigen
    • 3.3.2: Polysaccharide Antigen
  • 3.4: Global Subunit Vaccine Market by Disease
    • 3.4.1: Infectious Disease
    • 3.4.2: Diphtheria
    • 3.4.3: Tetanus and Pertussis (DTP)
    • 3.4.4: HPV
    • 3.4.5: Measles
    • 3.4.6: Mumps and Rubella (MMR)
    • 3.4.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Subunit Vaccine Market by Region
  • 4.2: North American Subunit Vaccine Market
    • 4.2.2: North American Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others
  • 4.3: European Subunit Vaccine Market
    • 4.3.1: European Subunit Vaccine Market by Product Type: Protein Antigen and Polysaccharide Antigen
    • 4.3.2: European Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others
  • 4.4: APAC Subunit Vaccine Market
    • 4.4.1: APAC Subunit Vaccine Market by Product Type: Protein Antigen and Polysaccharide Antigen
    • 4.4.2: APAC Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others
  • 4.5: ROW Subunit Vaccine Market
    • 4.5.1: ROW Subunit Vaccine Market by Product Type: Protein Antigen and Polysaccharide Antigen
    • 4.5.2: ROW Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Subunit Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Subunit Vaccine Market by Disease
    • 6.1.3: Growth Opportunities for the Global Subunit Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Subunit Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Subunit Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Subunit Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare Life Sciences
  • 7.2: GlaxoSmithKline
  • 7.3: Merck
  • 7.4: Reber Genetics
  • 7.5: Sanofi
  • 7.6: Algenex
  • 7.7: Astellas Pharma